As of now the Tomosynthesis Mammographic Imaging Screening Trial (TMIST) has enrolled 16,505 participants across a number of certified mammography clinics in the U.S., Canada and Argentina, with more sites and participants to come.
“Because BI-RADS 3 breast lesions have up to 2% likelihood of malignancy, it is imperative that optimal follow-up of BI-RADS 3 test results be addressed...," authors of the new study published in JACR wrote.
The researchers analyzed 39 consecutive patients with 44 pathologically confirmed cirrhotic nodules who first received a CEUS exam, followed by a traditional follow-up ultrasound every three or four months for their study.
“Machine learning is a low-cost and efficient tool that could help physicians arrive to a quicker decision as to how to approach an indeterminate nodule,” lead author of the study, John Eisenbrey, PhD, said.
“This technology has incredible potential to improve care, whether it is by better training doctors to perform procedures or helping patients know what to expect when they arrive at the hospital,” Ziv Haskal, creator of the technology said.
Exposure to radioiodine can lead to DNA damage in thyroid cells and other tissue, but new research suggests current radiation protection principles may not be sufficiently monitoring radiation exposure to nuclear medicine professionals.